Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new page revision label 'Revision: v3.5.3' has been added, signaling a version update to the page. This update does not modify the study content, eligibility criteria, or displayed data.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRevision tag updated: v3.5.2 added; v3.5.0 removed.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Esophageal Carcinoma as a related topic and included a Resources entry for the Genetic and Rare Diseases Information Center on the page. This expands disease-topic coverage and provides an additional patient information resource.SummaryDifference0.1%

- Check45 days agoChange DetectedA new Revision: v3.5.0 is added. The Revision: v3.4.3 entry is removed.SummaryDifference0.0%

- Check60 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision: v3.4.2 was added to the site footer; the funding notice and Revision: v3.4.1 text were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.